Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Bronx, NY
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Johnson City, NY
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Johnson City, NY
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Mineola, NY
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Mineola, NY
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
New York City, NY
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
New York City, NY
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Stony Brook, NY
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Concord, NC
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Concord, NC
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Cleveland, OH
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Columbus, OH
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Franklin, OH
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Franklin, OH
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Oklahoma City, OK
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Tulsa, OK
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Portland, OR
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
mi
from
Camphill, PA
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
mi
from
Camphill, PA
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Danville, PA
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Danville, PA
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Doylestown, PA
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Doylestown, PA
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Lancaster, PA
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Lancaster, PA
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Providence, RI
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Providence, RI
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Orangeburg, SC
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Orangeburg, SC
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Nashville, TN
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Oak Ridge, TN
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Oak Ridge, TN
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Tullahoma, TN
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Tullahoma, TN
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Dallas, TX
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Houston, TX
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
San Antonio, TX
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
mi
from
Whitney, TX
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
mi
from
Whitney, TX
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Danville, VA
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Danville, VA
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Olympia, WA
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Olympia, WA
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Tacoma, WA
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Charleston, WV
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Charleston, WV
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
mi
from
Buenos Aires,
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
mi
from
Buenos Aires,
Click here to add this to my saved trials
Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients
Randomized,Multi-center,Phase IV, 2-arm,Open-Label,Cross-over Study to Demonstrate the Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients
Status: Enrolling
Updated:  12/11/2015
St. Raphael's Dialysis Center
mi
from
New Haven, CT
Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients
Randomized,Multi-center,Phase IV, 2-arm,Open-Label,Cross-over Study to Demonstrate the Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients
Status: Enrolling
Updated: 12/11/2015
St. Raphael's Dialysis Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients
Randomized,Multi-center,Phase IV, 2-arm,Open-Label,Cross-over Study to Demonstrate the Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients
Status: Enrolling
Updated:  12/11/2015
North Haven Dialysis
mi
from
North Haven, CT
Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients
Randomized,Multi-center,Phase IV, 2-arm,Open-Label,Cross-over Study to Demonstrate the Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients
Status: Enrolling
Updated: 12/11/2015
North Haven Dialysis
mi
from
North Haven, CT
Click here to add this to my saved trials
Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients
Randomized,Multi-center,Phase IV, 2-arm,Open-Label,Cross-over Study to Demonstrate the Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients
Status: Enrolling
Updated:  12/11/2015
Irving Place Dialysis Center
mi
from
New York, NY
Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients
Randomized,Multi-center,Phase IV, 2-arm,Open-Label,Cross-over Study to Demonstrate the Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients
Status: Enrolling
Updated: 12/11/2015
Irving Place Dialysis Center
mi
from
New York, NY
Click here to add this to my saved trials
Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients
Randomized,Multi-center,Phase IV, 2-arm,Open-Label,Cross-over Study to Demonstrate the Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients
Status: Enrolling
Updated:  12/11/2015
Upper Manhattan Dialysis Clinic (UMDC)
mi
from
New York, NY
Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients
Randomized,Multi-center,Phase IV, 2-arm,Open-Label,Cross-over Study to Demonstrate the Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients
Status: Enrolling
Updated: 12/11/2015
Upper Manhattan Dialysis Clinic (UMDC)
mi
from
New York, NY
Click here to add this to my saved trials
Pharmacokinetic Comparison Of All FK-506 Formulations
A Steady-state Pharmacokinetic Comparison Of All FK-506 Formulations
Status: Enrolling
Updated:  12/11/2015
University of Cincinnati
mi
from
Cincinnati, OH
Pharmacokinetic Comparison Of All FK-506 Formulations
A Steady-state Pharmacokinetic Comparison Of All FK-506 Formulations
Status: Enrolling
Updated: 12/11/2015
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Hypertension in Hemodialysis Patients (Aim 3)
Hypertension in Hemodialysis Patients
Status: Enrolling
Updated:  12/14/2015
Indiana University
mi
from
Indianapolis, IN
Hypertension in Hemodialysis Patients (Aim 3)
Hypertension in Hemodialysis Patients
Status: Enrolling
Updated: 12/14/2015
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Randomized Trial of Induction Therapies in High Immunological Risk Kidney Transplant Recipients
Targeted Therapy for High Immunologic Risk Renal Transplant Recipients: A Prospective, Randomized, Open-Label Pilot Study of B-Cell Depleting Therapy in Combination With Anti-Thymocyte Globulin [Rabbit] (Thymoglobulin®, Genzyme), Tacrolimus (Prograf®, Astellas), Mycophenolate Mofetil (CellCept®, Roche) and Corticosteroid Minimization
Status: Enrolling
Updated:  12/14/2015
The University Hospital
mi
from
Cincinnati, OH
Randomized Trial of Induction Therapies in High Immunological Risk Kidney Transplant Recipients
Targeted Therapy for High Immunologic Risk Renal Transplant Recipients: A Prospective, Randomized, Open-Label Pilot Study of B-Cell Depleting Therapy in Combination With Anti-Thymocyte Globulin [Rabbit] (Thymoglobulin®, Genzyme), Tacrolimus (Prograf®, Astellas), Mycophenolate Mofetil (CellCept®, Roche) and Corticosteroid Minimization
Status: Enrolling
Updated: 12/14/2015
The University Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Randomized Trial of Induction Therapies in High Immunological Risk Kidney Transplant Recipients
Targeted Therapy for High Immunologic Risk Renal Transplant Recipients: A Prospective, Randomized, Open-Label Pilot Study of B-Cell Depleting Therapy in Combination With Anti-Thymocyte Globulin [Rabbit] (Thymoglobulin®, Genzyme), Tacrolimus (Prograf®, Astellas), Mycophenolate Mofetil (CellCept®, Roche) and Corticosteroid Minimization
Status: Enrolling
Updated:  12/14/2015
The Christ Hospital
mi
from
Cincinnati, OH
Randomized Trial of Induction Therapies in High Immunological Risk Kidney Transplant Recipients
Targeted Therapy for High Immunologic Risk Renal Transplant Recipients: A Prospective, Randomized, Open-Label Pilot Study of B-Cell Depleting Therapy in Combination With Anti-Thymocyte Globulin [Rabbit] (Thymoglobulin®, Genzyme), Tacrolimus (Prograf®, Astellas), Mycophenolate Mofetil (CellCept®, Roche) and Corticosteroid Minimization
Status: Enrolling
Updated: 12/14/2015
The Christ Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
UCSD Medical Center
mi
from
La Jolla, CA
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
UCSD Medical Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
Long Beach CA VA Hospital
mi
from
Long Beach, CA
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
Long Beach CA VA Hospital
mi
from
Long Beach, CA
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
Kaiser Permanente Los Angeles Medical Center
mi
from
Los Angeles, CA
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
Kaiser Permanente Los Angeles Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
Stanford Hospital and Clinics
mi
from
Stanford, CA
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
Stanford Hospital and Clinics
mi
from
Stanford, CA
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
Harbor UCLA Medical Center
mi
from
Torrance, CA
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
Harbor UCLA Medical Center
mi
from
Torrance, CA
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
The Heart & Vascular Institute Of Florida
mi
from
Clearwater, FL
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
The Heart & Vascular Institute Of Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
St. Vincent's Ambulatory Care (dba St. Vincent's Cardiology)
mi
from
Jacksonville, FL
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
St. Vincent's Ambulatory Care (dba St. Vincent's Cardiology)
mi
from
Jacksonville, FL
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
University of FL College of Medicine - Jacksonville
mi
from
Jacksonville, FL
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
University of FL College of Medicine - Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
Tallahassee Research Institute
mi
from
Tallahassee, FL
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
Tallahassee Research Institute
mi
from
Tallahassee, FL
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
Emory University Hospital Midtown
mi
from
Atlanta, GA
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
Emory University Hospital Midtown
mi
from
Atlanta, GA
Click here to add this to my saved trials